5-10-15-20-tetrakis(m-hydroxyphenyl)bacteriochlorin has been researched along with Colorectal-Neoplasms* in 2 studies
2 trial(s) available for 5-10-15-20-tetrakis(m-hydroxyphenyl)bacteriochlorin and Colorectal-Neoplasms
Article | Year |
---|---|
Photodynamic therapy with 5,10,15,20-tetrakis(m-hydroxyphenyl) bacteriochlorin for colorectal liver metastases is safe and feasible: results from a phase I study.
The prognosis for patients with liver metastases from colorectal carcinoma is limited because of the low number of patients who are eligible for curative hepatic resection. In this phase I study, 31 liver metastases in 24 patients with nonresectable metastases from colorectal carcinoma were treated with photodynamic therapy (PDT).. The photosensitizer 5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin (mTHPBC) was intravenously administered in a dose of .6 mg/kg (n = 12) or .3 mg/kg (n = 12). After 120 hours (n = 18) or 48 hours (n = 6), tumors were illuminated for 300 to 600 seconds through percutaneously inserted optical fibers with a light dose of 60 J/cm of diffuser (740 nm).. Tumor necrosis at 1 month after PDT was achieved in all treated lesions. Laser treatment was associated with mild pain (n = 8) and transient subclinical hepatotoxicity (n = 21). In one patient, PDT damage to the pancreas was inflicted, and in another patient, PDT damage of the skin occurred, but no serious clinical complications from PDT were reported. Administration of .6 mg/kg of mTHPBC led to transient phlebitis in 10 patients, and 3 patients experienced mild skin phototoxicity after excess light exposure.. Colorectal liver metastases that are ineligible for resection can be safely and effectively treated with interstitial mTHPBC-based PDT. Topics: Adult; Aged; Colorectal Neoplasms; Female; Humans; Infusions, Intravenous; Laser Therapy; Liver Neoplasms; Male; Middle Aged; Photochemotherapy; Porphyrins; Skin | 2005 |
[Interstitial photodynamic laser therapy for liver metastases: first results of a clinical phase I-study].
Development and evaluation of a new photodynamic treatment technique for the laser therapy of liver malignancies. The combination with new catheter systems enables the use of the photodynamic therapy (PDT) to treat also tumors in parenchymal organs. So far it is mainly used to treat superficial or endoluminal tumors. The presented study is part of a multicenter phase I-study. We treated 5 patients with colorectal liver metastases with the new photosensitizer SQN 400 and following interstitial photodynamic laser treatment. Evaluation of tumors were performed by contrast-enhanced CT scans.. In the contrast enhanced CT scans the development of a complete necrosis within a radius of 1 cm around every single fibre could be shown. Additional the ablation of tumors with the combined use of several fibres is possible. Severe complications or toxicities were not observed.. The photodynamic laser therapy of liver malignancies is a minimal invasive procedure with little side effects which produces sharply defined yet small volumes of necrosis. Topics: Aged; Colorectal Neoplasms; Female; Hematoporphyrin Photoradiation; Humans; Image Enhancement; Injections, Intralesional; Liver; Liver Neoplasms; Male; Middle Aged; Necrosis; Porphyrins; Tomography, X-Ray Computed | 2003 |